Gelonghui May 9th 丨Kehua Biology (002022.SZ) announced that recently, Shanghai Kehua Bioengineering Co., Ltd. received the “Medical Device Registration Certificate” (in vitro diagnostic reagent) issued by the Shanghai Drug Administration. It is a lipoprotein (a) test kit (latex immunization turbidity method).
科华生物(002022.SZ)：“脂蛋白(a)测定试剂盒(胶乳免疫比浊法)”获得医疗器械注册证
Kehua Biotech (002022.SZ): “Lipoprotein (a) Determination Kit (Latex Immune Turbidimetry)” obtained a medical device registration certificate
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.